|
Topics in Respiratory version 4
Getting to know your respiratory drugs
- Beta2 agonist bronchodilators
- Short-acting beta2 agonists
- Long-acting beta2 agonists
- Anticholinergic bronchodilators
- Corticosteroids: use in respiratory disease
- Inhaled corticosteroids
- Intranasal corticosteroids
- Systemic corticosteroids in respiratory disease
- Cromolyns
- Leukotriene receptor antagonists
- Theophylline
- Omalizumab
- Neuraminidase inhibitors
- Antihistamines
- Mucolytics
- Decongestants
- Cough and cold preparations
- Use of respiratory drugs in competitive sport
- Drug-induced lung disease
Inhalational drug delivery devices
- General principles for inhalational devices
- Importance of correct technique
- Device choice
- Use of devices in children
- Pressurised metered dose inhalers
- Spacer devices
- Breath-activated metered dose devices
- Dry powder inhalers
- Nebulisers
- Summary table of inhalational devices
- Asthma: general principles of management
- Diagnosis of asthma
- Asthma control and severity
- Achieving good asthma control
- Trigger factors
- Drug treatment for asthma
- Other aspects of asthma management
- Primary risk factors for asthma
Asthma: treatment of an acute attack
- Risk factors and assessment
- Treatment
Chronic obstructive pulmonary disease
- Pathophysiology
- Assessment of COPD
- Management of chronic stable COPD
- Acute exacerbations of COPD
Guide to pulmonary function testing and thoracic imaging
- Pulmonary function tests
- Thoracic imaging
Cough
- Acute cough
- Persistent cough
- Persistent cough in ‘at risk’ individuals
- Chronic productive cough
- Chronic nonproductive cough
- Nonspecific management of cough
Rhinitis and rhinosinusitis
Croup
Acute bronchiolitis
Cystic fibrosis
- Lower airway infection
- Chest physiotherapy in cystic fibrosis
- Aerosolised mucolytics
- Inhaled bronchodilators
- Anti-inflammatory treatment
- Allergic bronchopulmonary aspergillosis
- Adherence to treatment in adolescence
Bronchiectasis
- Clinical features and diagnosis
- Management
Interstitial lung disease
- Idiopathic pulmonary fibrosis
- Nonspecific interstitial pneumonia
- Interstitial lung disease associated with autoimmune disease
- Other interstitial pneumonias
- Sarcoidosis
- The pneumoconioses
- Extrinsic allergic alveolitis (Hypersensitivity pneumonitis)
- Drug-induced interstitial lung disease
- Radiotherapy-induced alveolitis
- Paediatric interstitial lung disease
Pleural disease
- Pleuritic pain
- Pneumothorax
- Pleural effusion
- Malignant mesothelioma
Sleep-disordered breathing
- Adult sleep-disordered breathing
- Obstructive sleep apnoea
- Central sleep apnoea
- Obesity hypoventilation syndromes
- Overlap syndrome
- Paediatric sleep-disordered breathing
- Classification
- Diagnosis
- Treatment of childhood sleep-disordered breathing
Oxygen therapy
- Principles of oxygen administration
- Acute oxygen therapy in adults
- Indications
- Oxygen in patients at risk of hypercapnia
- Domiciliary oxygen therapy
Noninvasive ventilation
- Indications
- Contraindications to noninvasive ventilation
- Instituting treatment
- Treatment failure
- Ceasing noninvasive ventilation
Fitness for surgery
- Nature of the risks
- Risk groups
- Assessment
- Postoperative management
Fitness to fly
- Cabin environment
- Effects of reduced oxygen pressure
- Pre-flight assessment
- In-flight oxygen therapy
- In-flight continuous positive airways pressure
Fitness to scuba dive
- Respiratory conditions affecting fitness to scuba dive
- Assessment
Lung transplantation
- Issues in long-term management
- Infection
- Prevention of lung rejection
- Immunosuppressant drugs and their adverse effects
- Drug interactions in lung transplant patients
- Treatment of lung rejection
Pregnancy and breastfeeding
- Pregnancy and respiratory drugs
- Breastfeeding and respiratory drugs
Sources of information
- Patient support and information groups
- Institutions and professional organisations
Abbreviations Electronic version
Therapeutic Guidelines: Respiratory is available in electronic format as part of eTG complete.
|